10.1016/j.cmet.2022.09.007 [2] Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial. Diabetes Care 1 March 20 ...
研究成果以“通过综合临床与临床前研究鉴定FerroTerminator1分子为治疗代谢功能障碍相关脂肪性肝炎的潜在药物(Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH)”为题,2024年8月13日在线发表于《细胞代谢》(Cell ...